全球尿液檢查市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計尿液檢查市場將從 2025 年的 46.2 億美元成長到 2034 年的 80.6 億美元，2026 年至 2034 年的複合年成長率為 6.39%。

受糖尿病、腎臟病和尿道感染等慢性疾病日益普遍的推動，全球尿液檢查市場正經歷穩定成長。尿液檢查因其非侵入性和成本效益，仍然是最常用的診斷方法之一。人們對預防醫學和常規健康檢查的日益重視，顯著加速了尿液檢查在醫院、診斷檢查室和居家照護機構中的應用。

自動化分析儀和數位化檢測解決方案等技術進步是市場擴張的主要驅動力。人工智慧 (AI) 和數據分析在診斷過程中的應用，提高了診斷的準確性和效率。此外，老年人口不斷成長，罹患泌尿系統和腎臟疾病的風險也隨之增加，進一步推動了全球對可靠診斷解決方案的需求。

未來，就地檢驗和家用診斷試劑盒的廣泛應用預計將推動市場成長。由於醫療服務可近性的提高和健康意識的增強，發展中地區的市場預計將快速成長。診斷技術的持續創新和個人化醫療的不斷發展將進一步鞏固市場成長勢頭。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球尿液檢查市場：依檢測類型分類

• 市場分析、洞察與預測
• 尿液生物化學檢驗
• 尿沉渣檢查

第5章 全球尿液檢查市場：依產品分類

• 市場分析、洞察與預測
• 裝置
• 消耗品

第6章：全球尿液檢查市場：依檢測方式分類

• 市場分析、洞察與預測
• 可攜式的
• 獨立版
• 桌面型
• 工作檯面
• 其他

第7章 全球尿液檢查市場：依應用領域分類

• 市場分析、洞察與預測
• 尿道感染
• 腎臟疾病
• 糖尿病
• 肝病
• 懷孕和生殖
• 其他

第8章：全球尿液檢查市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院
• 檢查室
• 居家醫療環境
• 其他

第9章 全球尿液檢查市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第10章 競爭格局

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第11章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Abbott
  • Siemens Healthineers
  • Becton Dickinson And Company（BD）
  • Thermo Fisher Scientific Inc
  • Bio-Rad Laboratories Inc
  • F. Hoffmann-La Roche Ltd
  • Beckman Coulter Inc
  • ACON Laboratories Inc
  • Arkray Inc
  • Trinity Biotech
  • Quidel Corporation

The Urinalysis Market size is expected to reach USD 8.06 Billion in 2034 from USD 4.62 Billion (2025) growing at a CAGR of 6.39% during 2026-2034.

The global urinalysis market is experiencing consistent growth driven by the increasing incidence of chronic diseases such as diabetes, kidney disorders, and urinary tract infections. Urinalysis remains one of the most commonly used diagnostic tests due to its non-invasive nature and cost-effectiveness. The growing emphasis on preventive healthcare and routine health check-ups has significantly boosted the adoption of urinalysis across hospitals, diagnostic laboratories, and home care settings.

Technological advancements, including automated analyzers and digital testing solutions, are major drivers of market expansion. The integration of artificial intelligence and data analytics into diagnostic processes is improving accuracy and efficiency. Additionally, the rising geriatric population, which is more susceptible to urinary and renal conditions, is further fueling demand for reliable diagnostic solutions worldwide.

In the future, the market is expected to benefit from the increasing adoption of point-of-care testing and home-based diagnostic kits. Developing regions are likely to witness rapid growth due to expanding healthcare access and awareness. Continuous innovation in diagnostic technologies and the growing trend of personalized healthcare will further strengthen the market's growth trajectory.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Testing Type

• Urine Biochemistry Testing
• Urine Sediment Testing

By Product

• Instruments
• Consumables

By Modality

• Portable
• Standalone
• Table Top
• Bench Top
• Others

By Application

• Urinary Tract Infections
• Kidney Diseases
• Diabetes
• Liver Diseases
• Pregnancy and Fertility
• Others

By End User

• Hospital
• Laboratory
• Home Care Setting
• Others

COMPANIES PROFILED

• Abbott, Siemens Healthineers, Becton Dickinson and Company BD, Thermo Fisher Scientific Inc, BioRad Laboratories Inc, F HoffmannLa Roche Ltd, Beckman Coulter Inc, ACON Laboratories Inc, Arkray Inc, Trinity Biotech, Quidel Corporation
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL URINALYSIS MARKET: BY TESTING TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Testing Type
• 4.2. Urine Biochemistry Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Urine Sediment Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL URINALYSIS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Product
• 5.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL URINALYSIS MARKET: BY MODALITY 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Modality
• 6.2. Portable Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Standalone Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Table Top Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Bench Top Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL URINALYSIS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Application
• 7.2. Urinary Tract Infections Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Kidney Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Diabetes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Liver Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Pregnancy and Fertility Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL URINALYSIS MARKET: BY END USER 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast End User
• 8.2. Hospital Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Laboratory Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Home Care Setting Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL URINALYSIS MARKET: BY REGION 2022-2034 (USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Testing Type
  • 9.2.2 By Product
  • 9.2.3 By Modality
  • 9.2.4 By Application
  • 9.2.5 By End User
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Testing Type
  • 9.3.2 By Product
  • 9.3.3 By Modality
  • 9.3.4 By Application
  • 9.3.5 By End User
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Testing Type
  • 9.4.2 By Product
  • 9.4.3 By Modality
  • 9.4.4 By Application
  • 9.4.5 By End User
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Testing Type
  • 9.5.2 By Product
  • 9.5.3 By Modality
  • 9.5.4 By Application
  • 9.5.5 By End User
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Testing Type
  • 9.6.2 By Product
  • 9.6.3 By Modality
  • 9.6.4 By Application
  • 9.6.5 By End User
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL URINALYSIS INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Abbott
  • 11.2.2 Siemens Healthineers
  • 11.2.3 Becton Dickinson And Company (BD)
  • 11.2.4 Thermo Fisher Scientific Inc
  • 11.2.5 Bio-Rad Laboratories Inc
  • 11.2.6 F. Hoffmann-La Roche Ltd
  • 11.2.7 Beckman Coulter Inc
  • 11.2.8 ACON Laboratories Inc
  • 11.2.9 Arkray Inc
  • 11.2.10 Trinity Biotech
  • 11.2.11 Quidel Corporation